Psyence BioMed Expands Australian Clinical Site Network to Five Sites, Advancing NPX-5–Supported Clinical Activities

Building on this foundation, the addition of Ramsay Health Care and NeuroCentrix expands the program to five sites, which is expected to strengthen recruitment, accelerate enrollment, and advance an ...
Nasdaq

Orchestra BioMed Receives FDA Breakthrough Device Designation for Atrioventricular Interval Modulation Therapy to Address Uncontrolled Hypertension

Orchestra BioMed has announced that the FDA has granted Breakthrough Device Designation for its atrioventricular interval modulation (AVIM) therapy, aimed at treating over 7.7 million U.S. patients ...
FierceBiotech

Orchestra BioMed stays on key in extended study of blood pressure reducing device

The latest study results for the BackBeat cardiac neuromodulation therapy device are music to Orchestra BioMed’s ears. The implant is meant to integrate with a patient’s existing pacemaker or other ...
The Business Journals

Texas Biomed wins designation that positions it for $100M in funding

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Heightened recognition and ...
Bisnow

BioMed To Buy South End Office Project From CIM, Nordblom, For Another Lab Pivot

BioMed Realty Trust continues to push the life sciences conversion wave in Boston, quietly taking over two prominent development sites. The Blackstone-backed life sciences investor has entered a ...